Alterations in neurotrophic tyrosine kinase (NTRK) genes (NTRK1, NTRK2, and NTRK3) are rare alterations in NSCLC, accounting for less than 1% of NSCLC cases141. This evidence concerns the gene NTRK2 and non-small cell lung carcinoma.